Amgen Com (AMGN) Share Price Rose While First Long Island Investors Has Trimmed Its Holding by $2.04 Million; Abraxas Petroleum (AXAS) Holder Portolan Capital Management Has Cut Position by $3.79 Million

Amgen Inc. (NASDAQ:AMGN) Logo

First Long Island Investors Llc decreased its stake in Amgen Inc Com (AMGN) by 8.4% based on its latest 2018Q2 regulatory filing with the SEC. First Long Island Investors Llc sold 11,063 shares as the company’s stock rose 8.61% with the market. The hedge fund held 120,612 shares of the biological products (no diagnostic substances) company at the end of 2018Q2, valued at $22.26 million, down from 131,675 at the end of the previous reported quarter. First Long Island Investors Llc who had been investing in Amgen Inc Com for a number of months, seems to be less bullish one the $125.00 billion market cap company. The stock decreased 0.80% or $1.59 during the last trading session, reaching $196.17. About 1.69 million shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 4.45% since December 6, 2017 and is uptrending. It has underperformed by 11.17% the S&P500. Some Historical AMGN News: 27/04/2018 – Amgen Receives Positive CHMP Opinion to Expand Use of Prolia(R) (denosumab) to Patients With Glucocorticoid-Induced Osteoporosis; 09/03/2018 – New Analyses Show Payer Utilization Management Criteria Deny Access To PCSK9 Inhibitors For Patients At The Highest Risk For Su; 24/04/2018 – Amgen, Inc. Cuts 2018 View To EPS $11.30-EPS $12.28; 24/04/2018 – AMGEN 1Q REV. $5.55B, EST. $5.43B; 17/05/2018 – BeyondSpring to Present Positive Data From Prospective Phase 2 Trial Comparing Plinabulin to Neulasta for the Prevention of Chemotherapy-lnduced Neutropenia at 2018 ASCO Annual Meeting; 19/04/2018 – New Novartis CEO feels heat on U.S. generics business; 12/04/2018 – Pfizer launches a gene therapy study for Duchenne MD; Amgen, NEA back real-world drug data software company; 24/04/2018 – AMGEN INC – 2018 TOTAL REVENUE OUTLOOK REVISED TO $21.9 BLN TO $22.8 BLN; 29/03/2018 – FDA expands use of Amgen leukemia drug Blincyto to patients with relapse risk; 05/04/2018 – ABBVIE REPORTS GLOBAL RESOLUTION OF HUMIRA┬« (ADALIMUMAB) PATENT

Portolan Capital Management Llc decreased its stake in Abraxas Petroleum Corporation (AXAS) by 29.49% based on its latest 2018Q2 regulatory filing with the SEC. Portolan Capital Management Llc sold 1.90M shares as the company’s stock declined 8.37% while stock markets rallied. The hedge fund held 4.53 million shares of the oil & gas production company at the end of 2018Q2, valued at $13.10M, down from 6.43 million at the end of the previous reported quarter. Portolan Capital Management Llc who had been investing in Abraxas Petroleum Corporation for a number of months, seems to be less bullish one the $260.35M market cap company. The stock decreased 6.80% or $0.115 during the last trading session, reaching $1.575. About 884,513 shares traded. Abraxas Petroleum Corporation (NASDAQ:AXAS) has risen 41.10% since December 6, 2017 and is uptrending. It has outperformed by 25.48% the S&P500. Some Historical AXAS News: 02/04/2018 – Abraxas Announces Spring Borrowing Base Redetermination and Presentation at IPAA OGIS New York; 02/04/2018 – Abraxas Announces Spring Borrowing Base Redetermination; 09/05/2018 – ABRAXAS PETROLEUM CORP AXAS.O : EURO PACIFIC CAPITAL RAISES TARGET PRICE TO $4 FROM $3.25; 05/04/2018 – Abraxas Petroleum Closes Above 50-Day Moving Average; 08/05/2018 – ABRAXAS PETROLEUM CORP QTRLY PRODUCTION OF 944 MBOE; 08/05/2018 – Abraxas Petroleum 1Q EPS 6c; 08/05/2018 – ABRAXAS SEES 2Q CAPEX $50M; 02/04/2018 – ABRAXAS PETROLEUM CORP – BORROWING BASE UNDER REVOLVING CREDIT FACILITY WAS INCREASED TO $175 MLN; 02/04/2018 – Abraxas Petroleum Presenting at IPAA Oil & Gas Conference Apr 9; 25/05/2018 – Abraxas Petroleum Closes Below 50-Day Moving Average

Portolan Capital Management Llc, which manages about $535.17M and $979.36M US Long portfolio, upped its stake in Lendingtree Inc. (NASDAQ:TREE) by 25,830 shares to 28,223 shares, valued at $6.03 million in 2018Q2, according to the filing. It also increased its holding in Carrols Restaurant Group Inc. (NASDAQ:TAST) by 660,116 shares in the quarter, for a total of 711,547 shares, and has risen its stake in Cambrex Corporation (NYSE:CBM).

More notable recent Abraxas Petroleum Corporation (NASDAQ:AXAS) news were published by: Seekingalpha.com which released: “Abraxas Petroleum: Production Now Expected To End Up At Lower End Of Guidance Range – Seeking Alpha” on October 28, 2018, also Bizjournals.com with their article: “Abraxas Petroleum executive resigns – San Antonio Business Journal” published on June 08, 2018, Seekingalpha.com published: “Abraxas Petroleum Could Have Over 45% Upside If Production Growth Meets Expectations – Seeking Alpha” on December 22, 2017. More interesting news about Abraxas Petroleum Corporation (NASDAQ:AXAS) were released by: Seekingalpha.com and their article: “Abraxas Petroleum reports 23% rise in Q3 production – Seeking Alpha” published on October 24, 2018 as well as Bizjournals.com‘s news article titled: “Shut in wells put Abraxas Petroleum in the red during second quarter – San Antonio Business Journal” with publication date: August 08, 2018.

Investors sentiment increased to 1.65 in Q2 2018. Its up 0.79, from 0.86 in 2018Q1. It is positive, as 10 investors sold AXAS shares while 39 reduced holdings. 29 funds opened positions while 52 raised stakes. 90.69 million shares or 8.77% more from 83.38 million shares in 2018Q1 were reported. Vantage Inv Advsr Limited Co accumulated 1,500 shares. Mangrove Prtn holds 3.70M shares. Zebra Mngmt Lc holds 0.06% in Abraxas Petroleum Corporation (NASDAQ:AXAS) or 44,959 shares. California Public Employees Retirement holds 0% of its portfolio in Abraxas Petroleum Corporation (NASDAQ:AXAS) for 1.09 million shares. Susquehanna International Gp Llp owns 30,929 shares for 0% of their portfolio. Deutsche Retail Bank Ag accumulated 264,725 shares. Moreover, Blackrock has 0% invested in Abraxas Petroleum Corporation (NASDAQ:AXAS). Invesco reported 10,202 shares stake. State Street Corporation reported 0% of its portfolio in Abraxas Petroleum Corporation (NASDAQ:AXAS). Barclays Pcl has 0% invested in Abraxas Petroleum Corporation (NASDAQ:AXAS). Old West Investment Ltd Com owns 749,659 shares for 1.09% of their portfolio. Retail Bank Of America Corp De accumulated 79,151 shares or 0% of the stock. Northern Tru owns 2.24 million shares. 605,200 are owned by Sigma Planning Corp. Strs Ohio accumulated 176,900 shares or 0% of the stock.

Analysts await Abraxas Petroleum Corporation (NASDAQ:AXAS) to report earnings on March, 12. They expect $0.08 EPS, up 100.00% or $0.04 from last year’s $0.04 per share. AXAS’s profit will be $13.22 million for 4.92 P/E if the $0.08 EPS becomes a reality. After $0.05 actual EPS reported by Abraxas Petroleum Corporation for the previous quarter, Wall Street now forecasts 60.00% EPS growth.

Among 11 analysts covering Abraxas Petroleum (NASDAQ:AXAS), 9 have Buy rating, 0 Sell and 2 Hold. Therefore 82% are positive. Abraxas Petroleum had 39 analyst reports since July 21, 2015 according to SRatingsIntel. On Friday, September 4 the stock rating was maintained by Euro Pacific Capital with “Buy”. Stifel Nicolaus maintained the stock with “Buy” rating in Wednesday, January 31 report. As per Friday, September 11, the company rating was maintained by Imperial Capital. Imperial Capital maintained Abraxas Petroleum Corporation (NASDAQ:AXAS) rating on Thursday, December 17. Imperial Capital has “In-Line” rating and $1 target. The firm has “Buy” rating by Canaccord Genuity given on Tuesday, May 8. Stifel Nicolaus maintained Abraxas Petroleum Corporation (NASDAQ:AXAS) on Thursday, October 5 with “Buy” rating. As per Tuesday, March 13, the company rating was maintained by Canaccord Genuity. The stock of Abraxas Petroleum Corporation (NASDAQ:AXAS) earned “Buy” rating by Canaccord Genuity on Tuesday, November 7. The rating was maintained by Stifel Nicolaus with “Buy” on Monday, April 23. Robert W. Baird initiated the stock with “Buy” rating in Tuesday, December 19 report.

More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: Nasdaq.com which released: “Health Care Sector Update for 11/21/2018: SYN, CYAD, JNJ, PFE, ABT, MRK, AMGN – Nasdaq” on November 21, 2018, also Seekingalpha.com with their article: “BeyondSpring up 17% on positive plinabulin data – Seeking Alpha” published on November 09, 2018, Nasdaq.com published: “Health Care Sector Update for 12/04/2018: CLVS, CRON, MO, PSTI, JNJ, PFE, MRK, ABT, AMGN – Nasdaq” on December 04, 2018. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: Nasdaq.com and their article: “FDA Committee to Review Amgen’s (AMGN) Osteoporosis Candidate – Nasdaq” published on December 03, 2018 as well as Nasdaq.com‘s news article titled: “Ex-Dividend Reminder: Aqua America, Amgen and Jones Lang LaSalle – Nasdaq” with publication date: November 13, 2018.

Among 27 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 16 Hold. Therefore 41% are positive. Amgen Inc. had 99 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was maintained by PiperJaffray with “Overweight” on Friday, July 27. The firm has “Buy” rating by UBS given on Monday, September 7. The rating was initiated by Gabelli with “Hold” on Friday, August 26. As per Monday, July 30, the company rating was maintained by Robert W. Baird. The rating was initiated by Wells Fargo with “Market Perform” on Friday, December 4. Jefferies maintained Amgen Inc. (NASDAQ:AMGN) rating on Thursday, September 28. Jefferies has “Buy” rating and $200.0 target. The rating was maintained by Barclays Capital on Friday, October 13 with “Equal-Weight”. The stock of Amgen Inc. (NASDAQ:AMGN) has “Buy” rating given on Monday, June 19 by Oppenheimer. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Buy” rating by Argus Research on Tuesday, January 23. The stock of Amgen Inc. (NASDAQ:AMGN) has “Neutral” rating given on Friday, February 2 by Credit Suisse.

Investors sentiment increased to 0.99 in Q2 2018. Its up 0.11, from 0.88 in 2018Q1. It increased, as 42 investors sold AMGN shares while 528 reduced holdings. 117 funds opened positions while 447 raised stakes. 483.36 million shares or 3.85% less from 502.72 million shares in 2018Q1 were reported. Daiwa Securities stated it has 0.05% in Amgen Inc. (NASDAQ:AMGN). Spectrum Mgmt Grp Inc holds 0% in Amgen Inc. (NASDAQ:AMGN) or 16 shares. Provident Inv has invested 0.35% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Artemis Investment Mngmt Llp has invested 0.12% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Fairfield Bush & reported 33,934 shares. Bradley Foster And Sargent Ct accumulated 14,890 shares. Marshwinds Advisory Communications reported 2.36% in Amgen Inc. (NASDAQ:AMGN). 99,000 were accumulated by St Germain D J Com. Univest Corporation Of Pennsylvania invested in 1.77% or 23,874 shares. Millennium Mgmt Lc holds 0.08% or 324,399 shares in its portfolio. Eqis Capital Management Incorporated has 42,769 shares for 0.48% of their portfolio. Royal Natl Bank Of Canada holds 0.29% or 3.52M shares. Tennessee-based Ftb Advsr has invested 0.52% in Amgen Inc. (NASDAQ:AMGN). Choate Inv Advsrs accumulated 23,209 shares. Moreover, Iberiabank has 0.83% invested in Amgen Inc. (NASDAQ:AMGN) for 25,968 shares.

Since June 12, 2018, it had 0 insider purchases, and 1 sale for $281,012 activity.

First Long Island Investors Llc, which manages about $805.84M and $700.39 million US Long portfolio, upped its stake in Baidu Inc Spon Adr Rptng (NASDAQ:BIDU) by 1,863 shares to 61,491 shares, valued at $14.94M in 2018Q2, according to the filing. It also increased its holding in Cognizant Technology Solutions (NASDAQ:CTSH) by 13,068 shares in the quarter, for a total of 195,090 shares, and has risen its stake in Starbucks Corp Com (NASDAQ:SBUX).

Analysts await Amgen Inc. (NASDAQ:AMGN) to report earnings on February, 7. They expect $3.25 earnings per share, up 12.46% or $0.36 from last year’s $2.89 per share. AMGN’s profit will be $2.07B for 15.09 P/E if the $3.25 EPS becomes a reality. After $3.69 actual earnings per share reported by Amgen Inc. for the previous quarter, Wall Street now forecasts -11.92% negative EPS growth.

Abraxas Petroleum Corporation (NASDAQ:AXAS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.